Description
What is KPV?
KPV is a short peptide fragment of α-MSH studied in controlled research settings for its role in inflammatory and immune signaling. In preclinical models, it’s been evaluated for its potential to modulate pro-inflammatory mediators (e.g., TNF-α, IL-6, NF-κB) and support mucosal/barrier integrity.
Research Focus Areas
Research on KPV commonly centers on systemic and localized inflammation models, gut/intestinal barrier integrity, immune-response modulation, and skin inflammation + tissue repair models.
Potential Research Benefits
-
Anti-inflammatory activity (models): studied for down-regulating pro-inflammatory signaling
-
Gut & mucosal integrity (models): used in leaky-gut/colitis-type research models
-
Immune modulation (models): explored for balancing immune response (not framed as suppressive)
-
Skin inflammation & repair (models): evaluated in eczema/psoriasis-like and wound models
-
Oxidative stress (models): investigated for reducing oxidative stress markers
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes. Supplied for in-vitro research only (“in glass”)—not for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have not been evaluated or approved by the FDA or any other regulatory agency. Any form of bodily introduction or therapeutic application is strictly prohibited.
